Will India Glycols Sustain Its Margin Recovery After a Strong Q2 Performance?
About India Glycols
India Glycols is a leading manufacturer of bio-based chemicals, glycols, spirits and nutraceutical ingredients. The company benefits from integrated production facilities and a diversified revenue mix spanning industrial chemicals, specialty chemicals and potable alcohol. Q2 results indicate strengthening demand recovery and improved cost absorption across product lines.
Q2 performance highlights notable improvements in profitability, aided by better realizations and efficiency gains, even as sequential revenue moderated slightly.
Financial Highlights (Q2 FY26)
| Metric | Q2 FY26 | YoY | QoQ |
|---|---|---|---|
| Revenue | ₹2,412 Cr | +13% | -4% |
| EBITDA | ₹157.76 Cr | +37% | +5% |
| EBITDA Margin | 6.54% | vs 5.39% | vs 5.99% |
| PAT | ₹65.06 Cr | +31% | -11% |
Revenue ₹2,412 Cr — YoY growth supported by stronger chemical segment demand, even as QoQ softness reflected seasonal trends.
EBITDA ₹157.76 Cr — expansion driven by lower input cost volatility and an improved product mix.
PAT ₹65.06 Cr — YoY profitability boosted by margin recovery, though QoQ decline came from higher finance and operational costs.
Track market setups with our premium Nifty Trade Signals.
Peer Comparison
| Company | Segment Focus | EBITDA Margin |
|---|---|---|
| India Glycols | Bio-based Chemicals | 6.54% |
| GNFC | Chemicals & Fertilizers | ~10% |
| Deepak Nitrite | Specialty Chemicals | ~18% |
India Glycols continues to improve its operating leverage despite operating in a margin-sensitive commodity-linked segment.
Strengths & Weaknesses
Strengths
|
Weaknesses
|
Opportunities & Threats
|
|
Valuation & Investment View
India Glycols continues to deliver a stable improvement in operating metrics, supported by its integrated model and rising interest in bio-based chemicals. Margin strength and increased EBITDA contribution remain key positives for the medium term.
Stay aligned with market trends using our exclusive BankNifty Trade Signals.
Investor Takeaway
Gulshan Khera, CFP®, notes that India Glycols’ improving margin trajectory and stable revenue base make it an interesting watch for investors tracking chemical-sector recovery. Explore deeper sector insights at Indian-Share-Tips.com, which is a SEBI Registered Advisory Services.
Related Queries on India Glycols Q2 Results
- India Glycols earnings review
- Chemical sector quarterly performance
- Bio-based chemical companies analysis
SEBI Disclaimer: The information provided in this post is for informational purposes only and should not be construed as investment advice. Readers must perform their own due diligence and consult a registered investment advisor before making any investment decisions.
